JS Greengard

Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V

MJ Heeb, Yumi Kojima, JS Greengard · Blood · 1995 · 127 citations · Full text

Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. The French Network on the behalf of INSERM

Sophie Gandrille, JS Greengard, Martine Alhenc‐Gelas et al. · Blood · 1995 · 119 citations · Full text

Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis

Barry M. Brenner, Ariella Zivelin, N. Lanir et al. · Blood · 1996 · 65 citations · Full text

Use of a generally applicable tissue factor--dependent factor V assay to detect activated protein C-resistant factor Va in patients receiving warfarin and in patients with a lupus anticoagulant

D. Le, JS Greengard, Vibhas S. Mujumdar et al. · Blood · 1995 · 49 citations · Full text

Pseudo-homozygous protein C resistance due to coinheritance of heterozygous factor V-R506Q and type I factor deficiency associated with thrombosis

JS Greengard · Thrombosis and Haemostasis · 1995 · 18 citations

Thrombopoiesis, Thrombosis, Venous Thrombosis +8